Funding for this research was provided by:
Cancerföreningen i Stockholm
Svenska Sällskapet för Medicinsk Forskning
Karolinska Institutet Foundations
KI Stockholm County Council The King Gustaf V Jubilee Fund
Swedish Breast Cancer Association
Märit and Hans Rausing’s Initiative Against Breast Cancer
Breast Cancer Theme Center BRECT
KI AstraZeneca Research Collaboration
Received: 24 July 2016
Accepted: 22 January 2018
First Online: 12 February 2018
Ethics approval and consent to participate
: All patients participating in the studies signed an informed consent. The studies were approved by the Regional Ethical Review Board in Stockholm, Sweden and are referred to as Dnr 2012/754–31/3, 2005/917–32, 2013/1739–32 and 2011/180–32.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.